Neurotech International Stock Total Asset
| NTI Stock | 0.04 0 2.70% |
Neurotech International fundamentals help investors to digest information that contributes to Neurotech International's financial success or failures. It also enables traders to predict the movement of Neurotech Stock. The fundamental analysis module provides a way to measure Neurotech International's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Neurotech International stock.
| Last Reported | Projected for Next Year | ||
| Total Assets | 3.3 M | 4.3 M |
Neurotech | Total Asset |
Neurotech International Company Total Asset Analysis
Neurotech International's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Neurotech International Total Asset | 12.21 M |
Most of Neurotech International's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neurotech International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Neurotech Total Assets
Total Assets |
|
Based on the latest financial disclosure, Neurotech International has a Total Asset of 12.21 M. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The total asset for all Australia stocks is notably lower than that of the firm.
Neurotech Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Neurotech International's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Neurotech International could also be used in its relative valuation, which is a method of valuing Neurotech International by comparing valuation metrics of similar companies.Neurotech International is regarded second in total asset category among its peers.
Neurotech Fundamentals
| Return On Equity | -2.24 | ||||
| Return On Asset | -1.3 | ||||
| Operating Margin | (65.47) % | ||||
| Current Valuation | 32.59 M | ||||
| Shares Outstanding | 1.04 B | ||||
| Shares Owned By Insiders | 32.54 % | ||||
| Shares Owned By Institutions | 2.22 % | ||||
| Price To Book | 6.72 X | ||||
| Price To Sales | 479.13 X | ||||
| Revenue | 1.96 K | ||||
| Gross Profit | (3.38 M) | ||||
| EBITDA | (8.24 M) | ||||
| Net Income | (5.07 M) | ||||
| Total Debt | 314.7 K | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (4.6 M) | ||||
| Earnings Per Share | (0.01) X | ||||
| Target Price | 0.6 | ||||
| Beta | 1.24 | ||||
| Market Capitalization | 38.56 M | ||||
| Total Asset | 12.21 M | ||||
| Retained Earnings | (41.56 M) | ||||
| Working Capital | 11.9 M | ||||
| Net Asset | 12.21 M |
About Neurotech International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Neurotech International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neurotech International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neurotech International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Neurotech Stock Analysis
When running Neurotech International's price analysis, check to measure Neurotech International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurotech International is operating at the current time. Most of Neurotech International's value examination focuses on studying past and present price action to predict the probability of Neurotech International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurotech International's price. Additionally, you may evaluate how the addition of Neurotech International to your portfolios can decrease your overall portfolio volatility.